Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asasantin vs Aspirin on Thromboxane B2 in Healthy Volunteers
NCT02268773Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2000
- Primary completion
- May 2000
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Phase 1, randomised, open-label trial of dipyridamole + aspirin in stroke (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Absolute serum thromboxane B2 level at Day 3. Started Jan 2000; status: completed.
02
Drugs
dipyridamole + aspirin
03
Conditions
stroke
Beyond the preview
Go deeper on NCT02268773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268773.